Skip to main content
. Author manuscript; available in PMC: 2019 Sep 4.
Published in final edited form as: Circulation. 2018 Sep 4;138(10):1039–1053. doi: 10.1161/CIRCULATIONAHA.118.034668

Figure 1.

Figure 1.

Proportion of cardiovascular trials with positive outcomes by the type of primary endpoint over time. Cardiovascular trials using intermediate or surrogate endpoints had similar proportions of positive outcomes over time, whereas trials including clinical endpoints had less positive outcomes over time. Analyses of temporal trends across trial time frames were performed using nonparametric tests for trend. Adapted with permission from Patel RB et al.5